Caribou Biosciences, Inc. (CRBU)
0.4439
-0.02
(-3.37%)
USD |
NASDAQ |
Nov 04, 16:00
0.4439
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Total Return Price : 0.4439 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 0.4594 |
| November 02, 2026 | 0.4399 |
| October 30, 2026 | 0.4232 |
| October 29, 2026 | 0.445 |
| October 28, 2026 | 0.4894 |
| October 27, 2026 | 0.4607 |
| October 26, 2026 | 0.4922 |
| October 23, 2026 | 0.5328 |
| October 22, 2026 | 0.56 |
| October 21, 2026 | 0.5444 |
| October 20, 2026 | 0.519 |
| October 19, 2026 | 0.464 |
| October 16, 2026 | 0.4699 |
| October 15, 2026 | 0.4647 |
| October 14, 2026 | 0.4601 |
| October 13, 2026 | 0.47 |
| October 12, 2026 | 0.4969 |
| October 09, 2026 | 0.4602 |
| October 08, 2026 | 0.4812 |
| October 07, 2026 | 0.6174 |
| October 06, 2026 | 1.135 |
| October 05, 2026 | 1.19 |
| October 02, 2026 | 1.22 |
| October 01, 2026 | 1.22 |
| September 30, 2026 | 1.27 |
| Date | Value |
|---|---|
| September 29, 2026 | 1.24 |
| September 28, 2026 | 1.23 |
| September 25, 2026 | 1.24 |
| September 24, 2026 | 1.25 |
| September 23, 2026 | 1.29 |
| September 22, 2026 | 1.34 |
| September 21, 2026 | 1.30 |
| September 18, 2026 | 1.30 |
| September 17, 2026 | 1.31 |
| September 16, 2026 | 1.25 |
| September 15, 2026 | 1.27 |
| September 14, 2026 | 1.29 |
| September 11, 2026 | 1.27 |
| September 10, 2026 | 1.37 |
| September 09, 2026 | 1.44 |
| September 08, 2026 | 1.54 |
| September 04, 2026 | 1.57 |
| September 03, 2026 | 1.57 |
| September 02, 2026 | 1.60 |
| September 01, 2026 | 1.55 |
| August 31, 2026 | 1.54 |
| August 28, 2026 | 1.62 |
| August 27, 2026 | 1.66 |
| August 26, 2026 | 1.65 |
| August 25, 2026 | 1.76 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Anavex Life Sciences Corp. | 1.255 |
| Intellia Therapeutics, Inc. | 12.31 |
| Vir Biotechnology, Inc. | 11.78 |
| Vaxcyte, Inc. | 65.65 |
| Foghorn Therapeutics, Inc. | 2.125 |